Objectives: Normal eosinophils can be found as high as 35 per high power field in lamina propria of the cecum. However, number of the eosinophils appears to be reduced along the mucosa to distal colon. This might represent an antigen process of food waste involved by eosinophils. A previous study suggests that more than 10 eosinophils in the rectal mucosa may represent an allergic etiology in pediatric population but the actual mean value of eosinophils in rectal mucosa in adults remains unclear. Methods: This study was to investigate the baseline level of eosinophils in rectal mucosa from men underwent trans-rectal prostate biopsies (assuming absence of gastrointestinal symptoms in them). From 30 men with incidental "snap-out" colonic mucosa present in our archival prostatic biopsies, the high eosinophil counts in the lamina propria of rectal mucosa per high power field were recorded. Results: Mean value ± standard error was 0.9 ± 0.26 (range 0-4 eosinophils), which was significantly lower than those of six adult positive controls (22.33 ± 3.11, ranging from 12 to 30 eosinophils per high power field) with either inflammatory bowel disease or unknown etiology of active colitis.
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Conclusion:
The evaluation of incidental rectal mucosa from prostate biopsies has provided us with normal range of rectal eosinophils not more than four eosinophils per high power field, compatible with a notion that rectal mucosa may be involved in less antigen processing than that of initial portion of colon (cecum). Progression to muscle-invasive disease significantly reduces five-year survival rates to 63% (SEER), and an important component of disease progression involves epithelial to mesenchymal transition. We therefore investigated E-cadherin expression and localization in the progression to pT1 and pT2 invasive disease. Methods: This retrospective study design involved 60 patients who had an initial diagnosis of pTa (NILG n = 7; NIHG n = 10), pTis (n = 30), and pT1 disease (n = 13), with a mean follow-up of 96 months to assess for progression. Initial biopsies diagnosed as pTa/pTis/pT1 disease were immunostained for E-cadherin, and membrane staining was evaluated for focal or extensive loss. Results: Of the 47 patients with non-invasive disease, we identified 20 progressors that included 0 NILG (0%), four NIHG (9%), and 16 patients with CIS (34%). Mean follow-up in these three cohorts was 93, 87, and 119 months, respectively. Loss of E-cadherin was identified in a small subset of these patients and included one of four NIHG progressors (25%), five of 16 CIS progressors (31%), and two of five pT1 progressors (40%). When comparing to the nonprogressor cohort, E-cadherin loss unexpectedly appeared equivalent to or more prevalent than the progressor cohort [one of six NIHG (17%), eight of 14 CIS (57%), and six of eight pT1 (75%) patients]. This data suggest that E-cadherin loss is not directly correlated to stage progression and outcomes, but rather related more closely to clinical stage at the time of diagnosis. Conclusion: E-cadherin loss occurs with increasing frequency in high-grade bladder cancers of increasing stage. Our results suggest that E-cadherin loss is intrinsic to more advanced cancers and may reflect possible transition to an epithelial-mesenchymal phenotype and/or increased cell dyscohesion in the context of invasion. 
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